The influence of drug-induced metabolic enzyme activity inhibition and CYP3A4 gene polymorphism on aumolertinib metabolism
Article in Frontiers in Pharmacology (May 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Exploring inter-ethnic and inter-patient variability and optimal dosing of osimertinib: a physiologically based pharmacokinetic modeling approach
Article in Frontiers in Pharmacology (March 2024)
Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort study
Article in Cancer Treatment and Research Communications (February 2024)